Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aflibercept

Brand: Eylea Ā®
NICE TA: 409
Indication: Visual impairment caused by macular oedema after branch retinal vein occlusion (NICE TA409)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Aflibercept is recommended as an option within its marketing authorisation for treating visual impairment in adults caused by macular oedema after branch retinal vein occlusion, only if the company provides aflibercept with the discount agreed in the patient access scheme.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red